Telesis Bio, Inc. (TBIO)

NASDAQ: TBIO · IEX Real-Time Price · USD
0.440
+0.010 (2.30%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.

Its solutions include BioXp system, including BioXp 3250 system, BioXp 9600 system, and BioXp DBC, which are empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits, such as BioXp De Novo kits, BioXp select kits, BioXp next generation sequencing kits, and BioXp DBC kits, which contains building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and short oligo ligation assembly enzymatic DNA synthesis designs to significantly reduce timelines for constructing synthetic DNA, RNA, and proteins compared to traditional chemical synthesis, paving the way for more efficient and effective development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines.

It also serves government institutions, contract research organizations, and synthetic biology companies.

The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022.

Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Telesis Bio, Inc.
Telesis Bio logo
Country United States
Founded 2013
IPO Date Jun 18, 2021
Industry Medical Devices
Sector Healthcare
Employees 223
CEO Dr. Todd R. Nelson MBA, Ph.D.

Contact Details

Address:
10431 Wateridge Circle, Suite 150
San Diego, California 92121
United States
Phone 858-228-4115
Website codexdna.com

Stock Details

Ticker Symbol TBIO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $16.00
CIK Code 0001850079
CUSIP Number 89374L104
ISIN Number US1920031010
Employer ID 45-1216839
SIC Code 3826

Key Executives

Name Position
Dr. Todd R. Nelson MBA, Ph.D. Founder, Chief Executive Officer and Director
Daniel G. Gibson Ph.D. Chief Technology Officer
Robert H. Cutler Chief Legal Officer
Eric Esser President and Chief Operating Officer
William J. Kullback Chief Financial Officer
Jen Carroll Vice President of Investor Relations
Decky Goodrich M.B.A. Senior Vice President of Corporate Development
Laura B. Puga M.B.A. Vice President of People and Culture
Laurence Warden Senior Vice President of Engineering and Instrumentation
Richard Lepke Director of Investor Relations

Latest SEC Filings

Date Type Title
Mar 28, 2024 8-K Current Report
Feb 26, 2024 8-K Current Report
Nov 30, 2023 8-K Current Report
Nov 13, 2023 10-Q Quarterly Report
Nov 13, 2023 8-K Current Report
Nov 9, 2023 8-K Current Report
Oct 24, 2023 8-K Current Report
Sep 22, 2023 8-K Current Report
Aug 29, 2023 8-K Current Report
Aug 11, 2023 10-Q Quarterly Report